Insider Selling: Vor Biopharma (NASDAQ:VOR) Director Sells 171,963 Shares of Stock

A director at Vor Biopharma (NASDAQ:VOR), RA Capital Management, L.P., recently sold 171,963 shares of the company’s stock for approximately $2.71 million, reducing their holding by 6.28%. This sale was part of a larger selling spree by RA Capital in early to mid-April, totaling around $46.8 million in VOR stock transactions. Despite these insider sales, analysts have a “Moderate Buy” consensus rating for Vor Biopharma with an average target price of $50.56.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin